TC Biopharm (Holdings) Plc

TCBP · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$5,907-$1,314-$13,576-$5,458
Dep. & Amort.$633$959$1,009$1,075
Deferred Tax$0$0$0$0
Stock-Based Comp.$444$1,123$0$805
Change in WC$1,540-$800-$592$1,729
Other Non-Cash-$7,255-$15,261$7,578-$1,583
Operating Cash Flow-$10,545-$15,292-$5,581-$3,432
Investing Activities
PP&E Inv.-$110-$241-$20-$35
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$98-$69-$123-$170
Investing Cash Flow-$209-$310-$143-$205
Financing Activities
Debt Repay.$0-$2,614$6,261-$415
Stock Issued$4,187$3,370$0$3,899
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$4,334$17,898-$21-$53
Financing Cash Flow$8,520$18,653$6,525$3,430
Forex Effect-$112$191$18-$2
Net Chg. in Cash-$2,345$3,241$819-$208
Supplemental Information
Beg. Cash$4,808$1,567$748$956
End Cash$2,463$4,808$1,567$748
Free Cash Flow-$10,655-$15,533-$5,601-$3,467
TC Biopharm (Holdings) Plc (TCBP) Financial Statements & Key Stats | AlphaPilot